BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 27551331)

  • 21. Regulatory effect between HMGA2 and the Wnt/β-catenin signaling pathway in the carcinogenesis of sporadic colorectal tubular adenoma.
    Li D; Cao Y; Wang J; Yang H; Liu W; Cui J; Wu W
    Oncol Lett; 2021 Dec; 22(6):849. PubMed ID: 34733367
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Bcl-w promoter is activated by beta-catenin/TCF4 in human colorectal carcinoma cells.
    Lapham A; Adams JE; Paterson A; Lee M; Brimmell M; Packham G
    Gene; 2009 Mar; 432(1-2):112-7. PubMed ID: 19124064
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer.
    Zhi X; Tao J; Xie K; Zhu Y; Li Z; Tang J; Wang W; Xu H; Zhang J; Xu Z
    Cancer Lett; 2014 Apr; 346(1):104-13. PubMed ID: 24374017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. RNA binding protein RBM3 increases β-catenin signaling to increase stem cell characteristics in colorectal cancer cells.
    Venugopal A; Subramaniam D; Balmaceda J; Roy B; Dixon DA; Umar S; Weir SJ; Anant S
    Mol Carcinog; 2016 Nov; 55(11):1503-1516. PubMed ID: 26331352
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Opposing Regulation of Cancer Properties via KRT19-Mediated Differential Modulation of Wnt/β-Catenin/Notch Signaling in Breast and Colon Cancers.
    Saha SK; Yin Y; Chae HS; Cho SG
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30650643
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Suppression of hath1 gene expression directly regulated by hes1 via notch signaling is associated with goblet cell depletion in ulcerative colitis.
    Zheng X; Tsuchiya K; Okamoto R; Iwasaki M; Kano Y; Sakamoto N; Nakamura T; Watanabe M
    Inflamm Bowel Dis; 2011 Nov; 17(11):2251-60. PubMed ID: 21987298
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The lncRNA NEAT1 activates Wnt/β-catenin signaling and promotes colorectal cancer progression via interacting with DDX5.
    Zhang M; Weng W; Zhang Q; Wu Y; Ni S; Tan C; Xu M; Sun H; Liu C; Wei P; Du X
    J Hematol Oncol; 2018 Sep; 11(1):113. PubMed ID: 30185232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Depletion of transmembrane mucin 4 (Muc4) alters intestinal homeostasis in a genetically engineered mouse model of colorectal cancer.
    Pothuraju R; Pai P; Chaudhary S; Siddiqui JA; Cox JL; Kaur S; Rachagani S; Roy HK; Bouvet M; Batra SK
    Aging (Albany NY); 2022 Mar; 14(5):2025-2046. PubMed ID: 35255004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differentiation-inducing factor-1 alters canonical Wnt signaling and suppresses alkaline phosphatase expression in osteoblast-like cell lines.
    Matsuzaki E; Takahashi-Yanaga F; Miwa Y; Hirata M; Watanabe Y; Sato N; Morimoto S; Hirofuji T; Maeda K; Sasaguri T
    J Bone Miner Res; 2006 Aug; 21(8):1307-16. PubMed ID: 16869729
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effective treatment of tumors with strong beta-catenin/T-cell factor activity by transcriptionally targeted oncolytic herpes simplex virus vector.
    Kuroda T; Rabkin SD; Martuza RL
    Cancer Res; 2006 Oct; 66(20):10127-35. PubMed ID: 17047077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of human nitric oxide synthase 2 expression by Wnt beta-catenin signaling.
    Du Q; Park KS; Guo Z; He P; Nagashima M; Shao L; Sahai R; Geller DA; Hussain SP
    Cancer Res; 2006 Jul; 66(14):7024-31. PubMed ID: 16849547
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IWR-1 inhibits epithelial-mesenchymal transition of colorectal cancer cells through suppressing Wnt/β-catenin signaling as well as survivin expression.
    Lee SC; Kim OH; Lee SK; Kim SJ
    Oncotarget; 2015 Sep; 6(29):27146-59. PubMed ID: 26450645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Knockdown of aquaporin-5 sensitizes colorectal cancer cells to 5-fluorouracil via inhibition of the Wnt-β-catenin signaling pathway.
    Li Q; Yang T; Li D; Ding F; Bai G; Wang W; Sun H
    Biochem Cell Biol; 2018 Oct; 96(5):572-579. PubMed ID: 29390193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activation of WNT/β-catenin signaling results in resistance to a dual PI3K/mTOR inhibitor in colorectal cancer cells harboring PIK3CA mutations.
    Park YL; Kim HP; Cho YW; Min DW; Cheon SK; Lim YJ; Song SH; Kim SJ; Han SW; Park KJ; Kim TY
    Int J Cancer; 2019 Jan; 144(2):389-401. PubMed ID: 29978469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-grade slightly elevated and polypoid colorectal adenomas display differential β-catenin-TCF/LEF activity, c-Myc, and cyclin D1 expression.
    Yang TW; Gao YH; Ma SY; Wu Q; Li ZF
    World J Gastroenterol; 2017 May; 23(17):3066-3076. PubMed ID: 28533663
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MNX1 promotes cell proliferation and activates Wnt/β-catenin signaling in colorectal cancer.
    Yang X; Pan Q; Lu Y; Jiang X; Zhang S; Wu J
    Cell Biol Int; 2019 Apr; 43(4):402-408. PubMed ID: 30614606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NOTCH1 activates the Wnt/β-catenin signaling pathway in colon cancer.
    Ishiguro H; Okubo T; Kuwabara Y; Kimura M; Mitsui A; Sugito N; Ogawa R; Katada T; Tanaka T; Shiozaki M; Mizoguchi K; Samoto Y; Matsuo Y; Takahashi H; Takiguchi S
    Oncotarget; 2017 Sep; 8(36):60378-60389. PubMed ID: 28947978
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The anti-cancer activity of an andrographolide analogue functions through a GSK-3β-independent Wnt/β-catenin signaling pathway in colorectal cancer cells.
    Reabroi S; Saeeng R; Boonmuen N; Kasemsuk T; Saengsawang W; Suksen K; Zhu W; Piyachaturawat P; Chairoungdua A
    Sci Rep; 2018 May; 8(1):7924. PubMed ID: 29784906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Wnt/β-catenin pathway transactivates microRNA-150 that promotes EMT of colorectal cancer cells by suppressing CREB signaling.
    Guo YH; Wang LQ; Li B; Xu H; Yang JH; Zheng LS; Yu P; Zhou AD; Zhang Y; Xie SJ; Liang ZR; Zhang CM; Zhou H; Qu LH
    Oncotarget; 2016 Jul; 7(27):42513-42526. PubMed ID: 27285761
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.